(PharmaNewsWire.Com, February 19, 2019 ) The Clinical Trial Management System Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.
The Global Clinical Trial Management System CTMS market is segmented on the basis of component, product, delivery mode, and end-user. The component segment includes, software and services. Based on product, the market is segmented as enterprise based and site based. Based on delivery mode, the market is segmented as, web based, cloud based and on premise. Based on end-user, the market is classified as, pharmaceutical & biopharmaceutical companies, clinical research organizations [CROs], medical device companies, and other end users.
A clinical trial management system CTMS is software system to accomplish clinical trial data operations generated by pharmaceutical and biotechnological companies. A CTMS manages up-to-date clinical data initiation from planning of research proposal to preparation, conducting and reporting generation. Clinical trial management system performs planning on budgets, report budgeting, clinical data management and report generation and accordingly the requirements of recipient companies vary from the future prospect.
1. Oracle 2. Medidata Solutions Inc. 3. PAREXEL International Corporation. 4. MedNet Solutions, Inc. 5. Bioclinica 6. BioOptronics, Inc. 7. DATATRAK Int. 8. ERT Clinical 9. FORTE 10. ICON plc
The increasing research and development activities in the field of health science and clinical research is the foremost factor driving the demand for CTMS. The growing investments from public and private sectors and the introduction of conducive government policies are paving way for increased number of clinical trials, which is expected to boast the Clinical Trial Management System CTMS market during the forecast period.
North America is expected to dominate this market in the forecast period due to favorable government initiatives, and support from government bodies. Also the raising awareness among people regarding diseases is expected to increase their participation in clinical trials. The Clinical Trial Management System CTMS market in Asia-Pacific is anticipated to grow during the forecast period owing to factors, such as huge, diverse patient pool, outsourcing of clinical trials to CROs, and rising healthcare facilities in the region.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Clinical Trial Management System CTMS market in these regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
